Female sexual dysfunction is a medical condition that involves persistent difficulties with sexual desire, arousal, orgasm, or pain during sex that cause personal distress. It affects up to 40% of women at some point in their lives and can occur at any age.
While it becomes more common after menopause, it is not limited to older adults. Female sexual dysfunction is a recognized health condition with several evidence-based treatment options that can help improve symptoms and quality of life.
- Female sexual dysfunction affects up to 40% of women and involves ongoing difficulties with desire, arousal, orgasm, or pain during sex that cause distress.
- Common causes include hormonal changes, menopause, certain medical conditions and medications, mental health concerns, trauma, and relationship issues.
- Treatment options include pelvic floor physiotherapy, CBT, mindfulness-based sex therapy, vaginal estrogen therapy, and FDA-approved medications such as Addyi and Vyleesi.
Read More: Why Women Experience Orgasm Dysfunction: 15 Key Reasons
What Female Sexual Dysfunction Is and What It Is Not
Female sexual dysfunction (FSD) is an umbrella term used to describe ongoing difficulties with one or more aspects of sexual response, including desire, arousal, orgasm, or pain during sexual activity. A key part of the diagnosis is personal distress.
Occasional changes in sexual interest or satisfaction are normal and do not automatically indicate a medical condition. For a diagnosis of female sexual dysfunction, symptoms must be persistent, recurrent, and cause genuine emotional or relationship distress.
FSD affects approximately 40% of women during their lifetime, making it one of the most common but least discussed women’s sexual health problems. Many women never discuss these concerns with a healthcare provider because of embarrassment, stigma, or the mistaken belief that sexual difficulties are simply something they must accept.
The Four Main Types: Updated DSM-5 Classification

The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) updated the classification of female sexual dysfunction in 2013 to better reflect current understanding of women’s sexual health.
Female Sexual Interest/Arousal Disorder (FSIAD)
FSIAD, female sexual interest arousal disorder, combines what were previously separate diagnoses of hypoactive sexual desire disorder and female sexual arousal disorder. Women with FSIAD may experience little interest in sexual activity, fewer sexual thoughts or fantasies, reduced pleasure during sexual activity, or difficulty becoming physically aroused.
Female Orgasmic Disorder
Female orgasmic disorder involves persistent difficulty reaching orgasm, significantly delayed orgasm, or a complete absence of orgasm despite adequate stimulation and arousal.
Genitopelvic Pain/Penetration Disorder (GPPPD)
Genitopelvic pain penetration disorder replaced the older diagnoses of dyspareunia and vaginismus. It includes persistent pain during penetration, fear or anxiety about pain during sexual activity, pelvic pain, and involuntary tightening of the pelvic floor muscles that can make penetration difficult or impossible.
These conditions can occur independently or together, and symptoms often overlap.
What Causes Female Sexual Dysfunction
Understanding what causes sexual dysfunction in women often requires looking at several areas of health at the same time. In most cases, there is not a single cause.
Biological Causes
Hormonal changes are among the most common contributors to female sexual dysfunction. During perimenopause and menopause, declining estrogen levels can lead to vaginal atrophy, reduced lubrication, and decreased genital sensitivity. These changes may make sexual activity uncomfortable or less pleasurable.
Some women also experience reduced sexual desire related to changes in testosterone levels. Postpartum hormonal shifts and breastfeeding-related estrogen suppression can contribute to vaginal dryness and lower libido.
Medical conditions that affect blood flow, nerve function, or pelvic anatomy can also play a role. These include diabetes, cardiovascular disease, multiple sclerosis, chronic pain disorders, and pelvic floor dysfunction.
Certain medications are known to affect sexual function. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are among the most common causes of medication-related sexual side effects. Other medications, including some birth control pills, blood pressure medications, antihistamines, and cancer treatments, may also affect desire, arousal, or orgasm.
Psychological Causes
Mental health has a strong influence on sexual function. Anxiety, depression, chronic stress, post-traumatic stress disorder (PTSD), and past sexual trauma can all contribute to female sexual dysfunction. Women with a history of trauma may benefit from trauma-informed care that addresses both emotional and physical aspects of recovery.
Relational Causes
Relationship dynamics can significantly influence sexual well-being. Ongoing conflict, poor communication, emotional distance, trust issues, and partner sexual dysfunction can all contribute to symptoms.
Because sexual health exists within a relationship context for many people, successful treatment often includes addressing communication and relationship concerns alongside physical symptoms.
Read More: Menopause and Sex Drive: Why Libido Changes and How to Reclaim It
Diagnosis: What to Expect When You See a Doctor

Many women feel nervous discussing sexual concerns with a healthcare provider, but these conversations are a normal part of medical care. Diagnosis usually begins with a detailed discussion about symptoms, sexual history, relationship factors, medical conditions, and medications.
Your doctor may ask when symptoms started, how often they occur, and how they affect your quality of life. A physical examination may be performed to evaluate vaginal health, signs of vaginal atrophy, skin conditions, or pelvic floor dysfunction. Blood tests may sometimes be ordered to assess hormone levels, thyroid function, or other underlying medical conditions.
Female sexual dysfunction is diagnosed when symptoms are persistent, recurrent, and cause personal distress. Diagnosis is not based on how often someone has sex or any specific type of sexual activity.
Depending on the findings, your doctor may refer you to a gynecologist, sexual medicine specialist, pelvic floor physiotherapist, or psychosexual therapist. Most importantly, FSD is a recognized medical condition, not a personal failing.
Evidence-Based Treatments: What the Research Supports

Treatment depends on the specific type of female sexual dysfunction and its underlying causes. The most effective treatment plans often combine multiple approaches.
Psychological and Sex Therapy
Cognitive behavioral therapy (CBT) for female sexual dysfunction treatment has some of the strongest research support available. CBT helps identify unhelpful thought patterns, reduce avoidance behaviors, improve communication, and address emotional barriers that may contribute to symptoms.
Mindfulness sex therapy has also gained strong scientific support in recent years. Research led by sexual health experts such as Dr. Lori Brotto has shown that mindfulness-based approaches can improve desire, arousal, and overall sexual satisfaction in women with FSD.
Pelvic Floor Physiotherapy
Pelvic floor physiotherapy for dyspareunia and vaginismus is considered a first-line treatment for genitopelvic pain penetration disorder. A pelvic floor physiotherapist evaluates muscle tension, coordination, and pain responses.
Treatment may include relaxation exercises, manual therapy, breathing techniques, biofeedback, and graduated vaginal dilation when appropriate. Many women are unaware that pelvic floor dysfunction can contribute to painful sex and that specialized treatment is available.
Local Hormonal Therapy for Menopause-Related FSD
For women experiencing vaginal atrophy and menopause symptoms, localized vaginal estrogen therapy can be highly effective. Available forms include creams, vaginal tablets, and vaginal rings. These treatments improve lubrication, vaginal tissue health, and comfort during intercourse.
Unlike systemic hormone therapy, local estrogen therapy delivers medication directly to vaginal tissues and has a different safety profile. Other options include ospemifene, an oral medication that acts on estrogen receptors, and prasterone (DHEA) vaginal suppositories, which provide a non-estrogen treatment alternative.
Pharmacological Treatments for HSDD and FSIAD
Flibanserin (Addyi) is approved for certain premenopausal women with HSDD (hypoactive sexual desire disorder) and FSIAD. It is taken daily and works by influencing the activity of serotonin, dopamine, and norepinephrine in the brain.
Patients should be aware that Addyi carries an FDA black box warning regarding alcohol use. Combining Addyi with alcohol can cause severe hypotension and syncope, which means dangerously low blood pressure and fainting.
Bremelanotide (Vyleesi), approved by the FDA in 2019, is another treatment option for premenopausal women with HSDD. Unlike Addyi, it is used as needed before anticipated sexual activity and works through a different biological pathway involving melanocortin receptors. Both medications require a medical evaluation and prescription.
Lifestyle Factors That Support Sexual Health

Lifestyle changes can support treatment and improve overall sexual well-being, although they should not replace professional care when symptoms are significant. Regular aerobic exercise improves cardiovascular health, blood flow, mood, and body confidence, all of which contribute to healthy sexual function.
Exercise can also reduce anxiety and depression, which are common contributors to female sexual dysfunction. Quitting smoking may improve genital blood flow and arousal. Prioritizing sleep and stress management can help reduce elevated cortisol levels that may suppress sexual desire.
Open communication with a partner remains one of the most effective relationship-based interventions for improving sexual satisfaction and addressing concerns together.
Read More: Is It Healthy to Use a Vibrator? What Science and Sexual-Health Experts Say
Conclusion
Female sexual dysfunction is common, treatable, and not something women should feel obligated to endure in silence. Research over the past decade has expanded the range of effective treatment options available, including pelvic floor physiotherapy, mindfulness-based sex therapy, CBT, localized hormonal treatments, and FDA-approved medications.
If sexual concerns are affecting your quality of life, the most important first step is discussing them with a qualified healthcare provider.
FAQs
Q. Is female sexual dysfunction common?
Yes. Female sexual dysfunction affects approximately 40% of women at some point in their lives, making it one of the most common women’s health conditions. It becomes more common during perimenopause and postmenopause. Many women do not seek help because of stigma, embarrassment, or lack of awareness that effective treatments are available.
Q. Can female sexual dysfunction be treated?
Yes. Female sexual dysfunction treatment is often highly effective when matched to the underlying cause. Options include pelvic floor physiotherapy for pain disorders, CBT and mindfulness-based sex therapy for desire and arousal concerns, localized hormonal treatment for menopause-related symptoms, and FDA-approved medications such as Addyi and Vyleesi. Most women who seek care experience meaningful improvement.
Q. When should I see a doctor about sexual dysfunction?
You should consider speaking with a healthcare provider if problems with desire, arousal, orgasm, or pain during sex have persisted for several months, occur repeatedly, and are causing personal distress. Female sexual dysfunction is a recognized medical condition. A doctor can identify possible causes and refer you to specialists such as gynecologists, pelvic floor physiotherapists, or psychosexual therapists when needed.
References
- American Psychological Association. (n.d.). PubMed Central (PMC) articles on female sexual dysfunction and sexual health. National Center for Biotechnology Information.
- American Psychological Association. (n.d.). PubMed Central (PMC) article on female sexual dysfunction and treatment approaches. National Center for Biotechnology Information.
- American Psychological Association. (n.d.). PubMed Central (PMC) article on women’s sexual health and dysfunction. National Center for Biotechnology Information.
- Mattioli 1885 Journals. (n.d.). Article accessed through PDF viewer.
- Mattioli 1885 Journals. (n.d.). Article accessed through PDF viewer.
- Ubie Health. (n.d.). Exercise boosts sexual desire in older adults.
In this Article















